Researchers developed a deep learning model that predicts Alzheimer’s progression with high accuracy, highlighting differences in disease progression across race and sex.
Eli Lilly reports tirzepatide MASH success during Q4 earnings
The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the
February 6, 2024